A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older

For most acute myeloid leukemia (AML) patients an allogeneic hematopoietic stem cell transplantation (HSCT) offers the highest chance of cure. The introduction of less toxic non-myeloablative conditioning (NMA) regimes enabled older and/or comorbid patients to be consolidated with an allogeneic HSCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Backhaus, Donata, Brauer, Dominic, Pointner, Rosmarie, Bischof, Lara, Vucinic, Vladan, Franke, Georg-Nikolaus, Niederwieser, Dietger, Platzbecker, Uwe, Jentzsch, Madlen, Schwind, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812784/
https://www.ncbi.nlm.nih.gov/pubmed/36195769
http://dx.doi.org/10.1038/s41409-022-01833-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812784/
https://www.ncbi.nlm.nih.gov/pubmed/36195769
http://dx.doi.org/10.1038/s41409-022-01833-0

Ejemplares similares